319
Views
0
CrossRef citations to date
0
Altmetric
Commentary

The Role of Epigenomics in the Neurodegeneration of Ataxia-Telangiectasia

&
Pages 137-141 | Published online: 05 May 2015

References

  • Sedgwick RP , BoderE . Progressive ataxia in childhood with particular reference to ataxia-telangiectasia . Neurology10 , 705 – 715 ( 1960 ).
  • Boder E . Ataxia-telangiectasia: some historic, clinical and pathologic observations . Birth Defects Orig. Artic. Ser.11 ( 1 ), 255 – 270 ( 1975 ).
  • Bundey S . Clinical and genetic features of ataxia-telangiectasia . Int. J. Radiat. Biol.66 , S23 – S29 ( 1994 ).
  • Lavin MF , ShilohY . Ataxia-telangiectasia: a multifaceted genetic disorder associated with defective signal transduction . Curr. Opin. Immunol.8 , 459 – 464 ( 1996 ).
  • Biton S , BarzilaiA , ShilohY . The neurological phenotype of ataxia-telangiectasia: solving a persistent puzzle . DNA Repair (Amst.)7 , 1028 – 1038 ( 2008 ).
  • Savitsky K , Bar-ShiraA , GiladSet al. A single ataxia telangiectasia gene with a product similar to PI-3 kinase . Science268 , 1749 – 1753 ( 1995 ).
  • Bakkenist CJ , KastanMB . DNA damage activates ATM through intermolecular autophosphorylation and dimer dissociation . Nature421 , 499 – 506 ( 2003 ).
  • Dar I , BitonS , ShilohY , BarzilaiA . Analysis of the ataxia telangiectasia mutated-mediated DNA damage response in murine cerebellar neurons . J. Neurosci.26 , 7767 – 7774 ( 2006 ).
  • Yang Y , HerrupK . Loss of neuronal cell cycle control in ataxia-telangiectasia: a unified disease mechanism . J. Neurosci.25 , 2522 – 2529 ( 2005 ).
  • Rimkus SA , KatzenbergerRJ , TrinhATet al. Mutations in string/CDC25 inhibit cell cycle re-entry and neurodegeneration in a Drosophila model of ataxia telangiectasia . Genes Dev.22 , 1205 – 1220 ( 2008 ).
  • Li J , ChenJ , VintersHV , GattiRA , HerrupK . Stable brain ATM message and residual kinase-active ATM protein in ataxia-telangiectasia . J. Neurosci.31 , 7568 – 7577 ( 2011 ).
  • Abel T , ZukinRS . Epigenetic targets of HDAC inhibition in neurodegenerative and psychiatric disorders . Curr. Opin. Pharmacol.8 , 57 – 64 ( 2008 ).
  • Agis-Balboa RC , PavelkaZ , KerimogluC , FischerA . Loss of HDAC5 impairs memory function: implications for Alzheimer’s disease . J. Alzheimers Dis.31 ( 1 ), 35 – 44 ( 2012 ).
  • Alagiakrishnan K , GillSS , FagarasanuA . Genetics and epigenetics of Alzheimer’s disease . Postgrad. Med. J.88 , 522 – 529 ( 2012 ).
  • Bakulski KM , RozekLS , DolinoyDC , PaulsonHL , HuH . Alzheimer’s disease and environmental exposure to lead: the epidemiologic evidence and potential role of epigenetics . Curr. Alzheimer Res.9 , 563 – 573 ( 2012 ).
  • Barbash S , SoreqH . Threshold-independent meta-analysis of Alzheimer’s disease transcriptomes shows progressive changes in hippocampal functions, epigenetics and microRNA regulation . Curr. Alzheimer Res.9 , 425 – 435 ( 2012 ).
  • Bihaqi SW , SchumacherA , MaloneyB , LahiriDK , ZawiaNH . Do epigenetic pathways initiate late onset al.zheimer disease (LOAD): towards a new paradigm . Curr. Alzheimer Res.9 , 574 – 588 ( 2012 ).
  • Coppieters N , DragunowM . Epigenetics in Alzheimer’s disease: a focus on DNA modifications . Curr. Pharm. Des.17 , 3398 – 3412 ( 2011 ).
  • Deaton AM , BirdA . CpG islands and the regulation of transcription . Genes Dev.25 , 1010 – 1022 ( 2011 ).
  • Konsoula Z , BarileFA . Epigenetic histone acetylation and deacetylation mechanisms in experimental models of neurodegenerative disorders . J. Pharmacol. Toxicol. Methods66 ( 3 ), 215 – 220 ( 2012 ).
  • Kinney SR , PradhanS . Ten eleven translocation enzymes and 5-hydroxymethylation in mammalian development and cancer . Adv. Exp. Med. Biol.754 , 57 – 79 ( 2013 ).
  • Kwok JB . Role of epigenetics in Alzheimer’s and Parkinson’s disease . Epigenomics2 , 671 – 682 ( 2010 ).
  • Maekawa M , WatanabeY . Epigenetics: relations to disease and laboratory findings . Curr. Med. Chem.14 , 2642 – 2653 ( 2007 ).
  • Kudo Y , TateishiK , YamamotoKet al. Loss of 5-hydroxymethylcytosine is accompanied with malignant cellular transformation . Cancer Sci.103 , 670 – 676 ( 2012 ).
  • Marques SC , OliveiraCR , PereiraCM , OuteiroTF . Epigenetics in neurodegeneration: a new layer of complexity . Prog. Neuropsychopharmacol. Biol. Psychiatry35 , 348 – 355 ( 2011 ).
  • Urdinguio RG , Sanchez-MutJV , EstellerM . Epigenetic mechanisms in neurological diseases: genes, syndromes, and therapies . Lancet Neurol.8 , 1056 – 1072 ( 2009 ).
  • Chouliaras L , RuttenBP , KenisGet al. Epigenetic regulation in the pathophysiology of Alzheimer’s disease . Prog. Neurobiol.90 , 498 – 510 ( 2010 ).
  • Ma DK , MarchettoMC , GuoJUet al. Epigenetic choreographers of neurogenesis in the adult mammalian brain . Nat. Neurosci.13 , 1338 – 1344 ( 2010 ).
  • Fagiolini M , JensenCL , ChampagneFA . Epigenetic influences on brain development and plasticity . Curr. Opin. Neurobiol.19 , 207 – 212 ( 2009 ).
  • Wang AH , BertosNR , VezmarMet al. HDAC4, a human histone deacetylase related to yeast HDA1, is a transcriptional corepressor . Mol. Cell. Biol.19 , 7816 – 7827 ( 1999 ).
  • Grozinger CM , HassigCA , SchreiberSL . Three proteins define a class of human histone deacetylases related to yeast Hda1p . Proc. Natl Acad. Sci. USA96 , 4868 – 4873 ( 1999 ).
  • Darcy MJ , CalvinK , CavnarK , OuimetCC . Regional and subcellular distribution of HDAC4 in mouse brain . J. Comp. Neurol.518 , 722 – 740 ( 2010 ).
  • Majdzadeh N , WangL , MorrisonBEet al. HDAC4 inhibits cell-cycle progression and protects neurons from cell death . Dev. Neurobiol.68 , 1076 – 1092 ( 2008 ).
  • Chen B , CepkoCL . HDAC4 regulates neuronal survival in normal and diseased retinas . Science323 , 256 – 259 ( 2009 ).
  • Youn HD , GrozingerCM , LiuJO . Calcium regulates transcriptional repression of myocyte enhancer factor 2 by histone deacetylase 4 . J. Biol. Chem.275 , 22563 – 22567 ( 2000 ).
  • Bolger TA , YaoTP . Intracellular trafficking of histone deacetylase 4 regulates neuronal cell death . J. Neurosci.25 , 9544 – 9553 ( 2005 ).
  • Li J , ChenJ , RicuperoCLet al. Nuclear accumulation of HDAC4 in ATM deficiency promotes neurodegeneration in ataxia telangiectasia . Nat. Med.18 , 783 – 790 ( 2012 ).
  • Cao R , ZhangY . The functions of E(Z)/EZH2-mediated methylation of lysine 27 in histone H3 . Curr. Opin. Genet. Dev.14 , 155 – 164 ( 2004 ).
  • Juan AH , DerfoulA , FengXet al. Polycomb EZH2 controls self-renewal and safeguards the transcriptional identity of skeletal muscle stem cells . Genes Dev.25 , 789 – 794 ( 2011 ).
  • Vire E , BrennerC , DeplusRet al. The Polycomb group protein EZH2 directly controls DNA methylation . Nature439 , 871 – 874 ( 2006 ).
  • Wei Y , ChenYH , LiLYet al. CDK1-dependent phosphorylation of EZH2 suppresses methylation of H3K27 and promotes osteogenic differentiation of human mesenchymal stem cells . Nat. Cell. Biol.13 , 87 – 94 ( 2011 ).
  • Wu Z , LeeST , QiaoYet al. Polycomb protein EZH2 regulates cancer cell fate decision in response to DNA damage . Cell Death Differ.18 ( 11 ), 1771 – 1779 ( 2011 ).
  • Francis NJ , FollmerNE , SimonMD , AghiaG , ButlerJD . Polycomb proteins remain bound to chromatin and DNA during DNA replication in vitro . Cell137 , 110 – 122 ( 2009 ).
  • Surface LE , ThorntonSR , BoyerLA . Polycomb group proteins set the stage for early lineage commitment . Cell Stem Cell7 , 288 – 298 ( 2010 ).
  • Sawarkar R , ParoR . Interpretation of developmental signaling at chromatin: the Polycomb perspective . Dev. Cell19 , 651 – 661 ( 2010 ).
  • Pirrotta V . PcG complexes and chromatin silencing . Curr. Opin. Genet. Dev.7 , 249 – 258 ( 1997 ).
  • Hirabayashi Y , SuzkiN , TsuboiMet al. Polycomb limits the neurogenic competence of neural precursor cells to promote astrogenic fate transition . Neuron63 , 600 – 613 ( 2009 ).
  • Sauvageau M , SauvageauG . Polycomb group proteins: multi-faceted regulators of somatic stem cells and cancer . Cell Stem Cell7 ( 3 ), 299 – 313 ( 2010 ).
  • Margueron R , ReinbergD . The polycomb complex PRC2 and its mark in life . Nature469 , 343 – 349 ( 2011 ).
  • Cao R , ZhangY . SUZ12 is required for both the histone methyltransferase activity and the silencing function of the EED-EZH2 complex . Mol. Cell15 , 57 – 67 ( 2004 ).
  • Sewalt RG , van der VlagJ , GunsterMJet al. Characterization of interactions between the mammalian polycomb-group proteins Enx1/EZH2 and EED suggests the existence of different mammalian polycomb-group protein complexes . Mol. Cell. Biol.18 , 3586 – 3595 ( 1998 ).
  • Li J , HartRP , MallimoEMet al. EZH2-mediated H3K27 trimethylation mediates neurodegeneration in ataxia-telangiectasia . Nat. Neurosci.16 , 1745 – 1753 ( 2013 ).

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.